PATENT CLAIM ANALYSIS

Application Number: 16282880
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-10
Patent Classification: ["514", "560000"]

Abstract:
The present invention relates generally to methods for the treatment and/or prophylaxis of neurological diseases and disorders involving administration of trans 10-HDA. In particular, the methods of the present invention are useful in the treatment and/or prophylaxis of acquired or progressive neurodevelopmental disorders and conditions in mammals. More particularly, methods are taught herein for the treatment and/or prophylaxis of diseases and disorders such as autism spectrum disorders.

Claim (Index 8):
The method according to  claim 1 , wherein the trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof is administered in a dosage in the range of 100 to 2000 mg/day.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15892144', '15316110', '15103470', '14925007', '15004218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7928166968777487
- 35 USC 102 Novelty (BERT): 0.6135952493643609
- Combined Prediction Score: 0.7748945521264099
- Mean Citation Score: 336.2826980000001
- Max Citation Score: 544.0127
- Similarity Product: 503.2211250077367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test